[1] Hongsakul K, Songjamrat A, Rookkapan S. Transarterial embolization for the treatment of massive bleeding in gynecologic and obstetric emergencies: a single center experience[J]. Emerg Radiol,2014,21(4):333-339. [2] Inoue S, Masuyama H, Hiramatsu Y. Efficacy of transarterial embolisation in the management of post-partum haemorrhage and its impact on subsequent pregnancies[J]. Aust N Z J Obstet Gynaecol,2014,54(6):541-545. [3]Salazar GM, Petrozza JC, Walker TG. Transcatheter endovascular techniques or management of obstetrical and gynecologic emergencies. Tech Vasc Interv Radiol.2009;12(2):139-47. [4] 张晓波,金征宇,向阳,等.超选择动脉栓塞术在妊娠滋养细胞肿瘤治疗中的价值[J]. 介入放射学杂志,2010(06):451-453. [5] 于昕,朱兰,史宏晖,等.再次子宫动脉栓塞术治疗获得性子宫动静脉瘘反复阴道流血临床疗效研究(附7例报告)[J]. 中国实用妇科与产科杂志,2016(05):450-452. [6] Cagayan M S. Vaginal metastases complicating gestational trophoblastic neoplasia[J]. J Reprod Med,2010,55(5-6):229-235. [7]Emma L. Barber, John T. Soper,Gestational Trophoblastic Disease[M],Clinical Gynecologic Oncology (Ninth Edition) 2018: 163-189. [8] 张敏鸽,严亚娃.子宫动静脉瘘诊治进展[J]. 中国妇产科临床杂志,2013(06):563-565. [9] Mcgrath S, Harding V, Lim A K, et al. Embolization of uterine arteriovenous malformations in patients with gestational trophoblastic tumors: a review of patients at Charing Cross Hospital, 2000-2009[J]. J Reprod Med,2012,57(7-8):319-324. [10] Touhami O, Gregoire J, Noel P, et al. Uterine arteriovenous malformations following gestational trophoblastic neoplasia: a systematic review[J]. Eur J Obstet Gynecol Reprod Biol,2014,181:54-59. [11]向阳.宋鸿钊.滋养细胞肿瘤学[M].3版.北京:人民卫生出版社,2011. [12] Froeling F E, Seckl M J. Gestational trophoblastic tumours: an update for 2014[J]. Curr Oncol Rep,2014,16(11):408. [13] Mangili G, Lorusso D, Brown J, et al. Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer Inter Group[J]. Int J Gynecol Cancer,2014,24(9 Suppl 3):S109-S116. [14] Biscaro A, Braga A, Berkowitz R S. Diagnosis, classification and treatment of gestational trophoblastic neoplasia[J]. Rev Bras Ginecol Obstet,2015,37(1):42-51. [15] Maesta I, Berkowitz R S, Goldstein D P, et al. Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia[J]. Gynecol Oncol,2015,138(1):50-54. [16] Chu M M, Ma Y, Tse K Y, et al. Cyclophosphamide, hydroxyurea, actinomycin D, methotrexate, and vincristine in the treatment of gestational trophoblastic neoplasia[J]. Int J Gynecol Cancer,2015,25(3):498-503. [17] Carlini L, Villa A, Busci L, et al. Selective uterine artery embolization: a new therapeutic approach in a patient with low-risk gestational trophoblastic disease[J]. Am J Obstet Gynecol,2006,195(1):314-315. [18] Wang Z, Li X, Pan J, et al. Bleeding from gestational trophoblastic neoplasia: embolotherapy efficacy and tumour response to chemotherapy[J]. Clin Radiol,2017,72(11):992-997. [19] Martin J, Bhanot K, Athreya S. Complications and reinterventions in uterine artery embolization for symptomatic duterine fibroids: a literature review and meta analysis[J]. Cardiovasc Intervent Radiol,2013,36(2):395-402. |